chemotherapy/inflammation

The present invention relates to a method for treating human subjects to prevent leakage of macromolecules from capillary endothelial junctions as a consequence of extremely severe and life threatening side effects due to cancer biological therapy for cancer, infectious diseases, septic shock, and

FIELD OF THE INVENTION The present invention relates to the use of human erythropoietin (EPO) in the prevention or treatment of endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or

FIELD OF THE INVENTION The present application is generally in the field of targeted polymeric nanoparticles which inhibit the inflammatory response, specifically Sub-100 micron multimodal nanoparticles which have four main components: 1) a targeting element that can selectively bind to cells,

FIELD OF THE INVENTION The present invention relates to methods for increasing the activity of the immune system and, especially, to methods for increasing the activity of the immune system by modulation of endogenous ectophosphatase levels. According to a particularly preferred embodiment, the

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to compositions and formulations of oligonucleotides and surfactants, which are highly effective for the prevention and treatment of diseases and conditions associated with difficult breathing, bronchoconstriction, impeded

TECHNICAL FIELD The presently disclosed subject matter generally relates to methods and compositions for inhibiting the expression and/or activation of hypoxia-inducible factor 1 (HIF-1) gene products in a hypoxic cell. More particularly, the presently disclosed subject matter provides methods and

BACKGROUND 1. Technical Field This document relates to methods and materials involved in treating cancer (e.g., melanoma). For example, this document relates to methods and materials involved in using an anti-chronic inflammation treatment (e.g., chemotherapy) in combination with a cancer treatment

BACKGROUND 1. Technical Field This document relates to methods and materials involved in treating cancer (e.g., melanoma). For example, this document relates to methods and materials involved in using an anti-chronic inflammation treatment (e.g., chemotherapy) in combination with a cancer treatment

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to an oral therapeutic apparatus comprising an oral device that is used to treat cancer patients undergoing chemotherapy treatments and a method of using the oral device. The oral device is formed to be insertable

FIELD OF THE INVENTION This invention relates to uses of nanoceria particles, and in particular to nanoceria-based methods, systems and devices useful in detecting reactive oxygen species and monitoring chronic inflammation in vivo. BACKGROUND AND PRIOR ART Most recently, it has been found that

RELATED APPLICATIONS This invention claims the benefit of priority from U.S. Utility patent application Ser. No. 12/924,976 filed Oct. 8, 2010 which claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 61/250,750 filed Oct. 12, 2009. The entire disclosure of each of the

FIELD OF THE INVENTION This invention relates to the field of treatment of tumors; more specifically to improved treatments using a combination cryosurgery (cryoablation) and injection of tumor inhibiting substances which provides a maximized effect on the tumor, protects normal cells, and activates

BACKGROUND The field of the invention relates to therapeutic peptides and prodrugs thereof. In particular, the field of the invention relates to therapeutic peptides which duplicate some of the beneficial effects of pigment epithelium-derived factor (PEDF), to which they are related, including

FIELD OF THE INVENTION This invention relates to the use of surfactant lipids for a variety of therapeutic uses, including the treatment of pulmonary inflammation and fibrosis. BACKGROUND OF THE INVENTION Pulmonary fibrosis (PF) is a complicated, chronic illness characterized by abnormal formation

FIELD OF THE INVENTION This invention relates to the use of surfactant lipids for a variety of therapeutic uses, including the treatment of pulmonary inflammation and fibrosis, vaginitis, and inflammatory conditions relating to the same. BACKGROUND OF THE INVENTION Pulmonary fibrosis (PF) is a